Financial Advocates Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $479K | Sell |
|
|||||
|
2025
Q1 | $1.07M | Buy |
|
|||||
|
2024
Q4 | $1.17M | Sell |
|
|||||
|
2024
Q3 | $2.11M | Buy |
|
|||||
|
2024
Q2 | $2.53M | Sell |
|
|||||
|
2024
Q1 | $2.99M | Buy |
|
|||||
|
2023
Q4 | $2.38M | Sell |
|
|||||
|
2023
Q3 | $2.12M | Buy |
|
|||||
|
2023
Q2 | $1.42M | Buy |
|
|||||
|
2023
Q1 | $1.33M | Buy |
|
|||||
|
2022
Q4 | $1.04M | Buy |
|
|||||
|
2022
Q3 | $560K | Sell |
|
|||||
|
2022
Q2 | $826K | Buy |
|
|||||
|
2022
Q1 | $660K | Buy |
|
|||||
|
2021
Q4 | $358K | Sell |
|
|||||
|
2021
Q3 | $312K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $215K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $292K | Sell |
|
|||||
|
2019
Q1 | $310K | Sell |
|
|||||
|
2018
Q4 | $280K | Sell |
|
|||||
|
2018
Q3 | $297K | Buy |
|
|||||
|
2018
Q2 | $291K | Buy |
|
|||||
|
2018
Q1 | $300K | Buy |
|
|||||
|
2017
Q4 | $326K | Buy |
|